Nanotechnology for diagnosis and therapy of rheumatoid arthritis: Evolution towards theranostic approaches

J Zhao, X Chen, KH Ho, C Cai, CW Li, M Yang… - Chinese Chemical …, 2021 - Elsevier
Rheumatoid arthritis (RA), as a chronic autoimmune disease, damages the bone and
cartilage of patients, and even leads to disability. Therefore, the diagnosis and treatment of …

Utilization of nanoparticle technology in rheumatoid arthritis treatment

S Dolati, S Sadreddini, D Rostamzadeh… - Biomedicine & …, 2016 - Elsevier
Rheumatoid arthritis (RA) is one of the common and severe autoimmune diseases related to
joints. This chronic autoimmune inflammatory disease, leads to functional limitation and …

Silk fibroin nanoparticles for celecoxib and curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthritis

B Crivelli, E Bari, S Perteghella, L Catenacci… - European Journal of …, 2019 - Elsevier
This paper aims at demonstrating silk fibroin nanoparticles (SFNs) promote anti-
inflammatory properties of celecoxib (CXB) or curcumin (CUR), and could be exploited for …

Nanotechnological strategies for osteoarthritis diagnosis, monitoring, clinical management, and regenerative medicine: recent advances and future opportunities

R Mohammadinejad, M Ashrafizadeh… - Current rheumatology …, 2020 - Springer
Abstract Purpose of Review In this review article, we discuss the potential for employing
nanotechnological strategies for the diagnosis, monitoring, and clinical management of …

Nanotechnology application in drug delivery to osteoarthritis (OA), rheumatoid arthritis (RA), and osteoporosis (OSP)

M Rabiei, S Kashanian, SS Samavati… - Journal of drug delivery …, 2021 - Elsevier
Nanoparticles (NPs) show great promise as tools for designing formulations capable of
meeting the challenge of targeted and non-targeted drug delivery to bone and cartilage …

Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis

J Zhao, M Zhao, C Yu, X Zhang, J Liu… - International journal …, 2017 - Taylor & Francis
Rheumatoid arthritis (RA) is an autoimmune disease characterized by progressive cartilage
and bone destruction. Activated macrophages that overexpress folic acid (FA) receptors play …

Drug delivery targets and systems for targeted treatment of rheumatoid arthritis

X Feng, Y Chen - Journal of drug targeting, 2018 - Taylor & Francis
Rheumatoid arthritis (RA) is an immune-mediated inflammatory disease that selectively
attacks human joints. The common non-targeted treatment approaches lead to obvious side …

[HTML][HTML] Hybrid micelles containing methotrexate-conjugated polymer and co-loaded with microRNA-124 for rheumatoid arthritis therapy

F Hao, RJ Lee, L Zhong, S Dong, C Yang, L Teng… - Theranostics, 2019 - ncbi.nlm.nih.gov
Purpose: Methotrexate (MTX) is a first-line drug for rheumatoid arthritis (RA) therapy.
However, MTX monotherapy often results in irreversible joint damage due to its slow onset …

Nanomedicine Strategies for Anti‐Inflammatory Treatment of Noninfectious Arthritis

L Chen, Y Wang, L Sun, J Yan… - Advanced Healthcare …, 2021 - Wiley Online Library
Noninfectious arthritis (NIA) comprises a class of chronic and progressive inflammatory
disorders that require early‐stage management to prevent disease progression. The most …

Nanomedicine for the effective and safe delivery of non-steroidal anti-inflammatory drugs: A review of preclinical research

H Al-Lawati, Z Binkhathlan, A Lavasanifar - European Journal of …, 2019 - Elsevier
The toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs) is one of the major limitations
to their long-term use in the treatment of chronic inflammatory conditions. This review …